Rare & Genetics Focus Day
9:29 am - Tuesday 16th March 2027
This year’s Rare & Genetic Kidney Disease Focus Day will explore how advances in genetics, biomarkers and disease-specific biology are reshaping the development of more precise therapies for inherited and rare kidney disorders. With a particular focus on ADPKD, the day will examine emerging small-molecule, RNA and gene therapy approaches alongside evolving trial designs, surrogate endpoints and regulatory strategies. By drawing lessons across PKD, FSGS, Alport syndrome, IgAN and other rare renal diseases, attendees will identify opportunities to accelerate development, improve patient selection and expand access to truly disease-modifying treatments.